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Background: To reduce the burden of disease from malaria, innovative approaches are needed to engender
behavior change. One unobservable, but fundamental trait—preferences for risk—may influence individuals’
willingness to adopt new health technologies. We explore the association of risk preferences with malaria
care-seeking behavior and the acceptability of malaria rapid diagnostic tests (RDTs) to inform RDT scale-up plans.
Methods: In Oyo State, Nigeria, adult customers purchasing anti-malarial medications at selected drug shops took
surveys and received an RDT as they exited. After an initial risk preference assessment via a simple lottery game
choice, individuals were given their RDT result and treatment advice, and called four days later to assess treatment
adherence. We used bivariable and multivariable regression analysis to assess the association of risk game choices
with malaria care-seeking behaviors and RDT acceptability.
Results: Of 448 respondents, 63.2% chose the lottery game with zero variance in expected payout, 27.9% chose the
game with low variance, and 8.9% chose the game with high variance. Compared to participants who chose lower
variance games, individuals choosing higher variance games were older, less educated, more likely to be male, and
were more likely to patronize lower quality drug shops, seek care immediately, and report complete disability due
to their illness. In contrast, individuals choosing lower variance games were more likely to follow the correct
treatment directions and were more likely to report an increase in their willingness to pay for an RDT compared to
other risk groups, our two measures of RDT acceptability. Differences in estimated associations between risk game
choices and selected care-seeking behaviors remained after controlling sociodemographic confounders.
Conclusions: The uptake of health diagnostic information in terms of translating the RDT experience into
willingness to pay for an RDT and treatment adherence to test results may vary according to risk preferences.
Hence, health promotion communications may want to be crafted bearing in mind differences in uptake among
people of different risk preferences to encourage wider RDT adoption and more rational malaria treatment.
Estimates will serve as the basis for power calculations for an expanded study.
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A number of new technologies offer great promise for
improving health outcomes in developing countries, in-
cluding deworming drugs, clean water systems, and
cleaner burning stoves [1,2]. However, adoption has been
slow and long-term behavior change has proven difficult
to sustain [3]. Prevailing preferences toward risk could
offer one explanation for depressed uptake. For example,
risk aversion, or the reluctance of a person to accept a
situation with an uncertain payoff rather than one with a
more certain but potentially lower payoff, may be a bar-
rier to accepting beneficial technology. Risk-averse
people may be more apt to follow past behaviors if try-
ing an innovation involves accepting a level of uncer-
tainty about the technology’s effectiveness. Unobserved
traits and specific preferences are theorized to influence
health-decision making (e.g. [4]) and recent empirical re-
search has confirmed associations of risk attitudes with
various health behaviors, including smoking, drinking,
and using seat belts [5]. Risk aversion has also served as
the basis for health behavior change interventions even
if not explicitly measured, such as those that seek to
help individuals to internalize and recognize risky sexual
practices [6].
Despite the theoretical importance of risk prefer-
ences, little is known about its relation to the accept-
ability of new health technologies. This study is an
initial investigation of the association of risk prefer-
ences with the acceptability of a new health technology—
the malaria rapid diagnostic test (RDT). This is part of a
larger pilot study of the quality of malaria diagnosis and
treatment at for-profit drug vendors conducted in Oyo
State, Nigeria.
Despite the scale-up of many malaria interventions [7],
increasing uptake of new health products and sustaining
behavior change remain challenging. Simply overcoming
income constraints via subsidies and micro-loans have
increased purchases of bed nets, artemisinin-based com-
bination therapies (ACTs), and RDTs, but results for
improving actual use of nets or treatment compliance
with test results have been disappointing [8,9].a While
ability to pay and socioeconomic status are important
factors in determining malaria care-seeking behavior
(e.g. [10,11]), seeking other root causes should be further
explored. Hence, understanding the fundamental drivers
of health behaviors and the underpinnings of behavior
change are important for developing appropriate inter-
vention delivery mechanisms that enhance adoption and
promote better prevention and treatment practices.
In sub-Saharan Africa, even though access to effective
malaria treatment with ACTs has increased [12], access to
reliable diagnostics is problematic, leading to concerns of
over-treatment, drug resistance, and lack of appropriate
treatment for non-malaria illnesses [13]. The malaria RDTis a reliable method for diagnosing uncomplicated malaria
and a cheap alternative to blood slide microscopy [14].
However, uptake and adherence remain challenging. Even
among trained providers, trust and acceptability of RDT
results are difficult to instill when clinical experience in
symptomatic diagnosis signal contradictory indications
[15]. Yet, acceptability has improved over time, resulting
in cost-savings from less over-treatment [16-19].
In Nigeria, nearly 60% of people with suspected mal-
aria seek care from private sector drug shops [20]. RDTs
are currently being rolled out in the public healthcare
sector [21], but more guidance on private sector delivery
is needed before expanding access. A recent nationwide
survey indicates that 14% of public and not-for-profit fa-
cilities stocked RDTs, but only 1.4% of private sector
outlets [22]. In addition, current regulatory guidelines
prohibit drug shops from performing diagnostic tests
even though they are the main sources for antimalarial
drugs. In other countries, provision of RDTs via private
sector channels has been more problematic than public
sector implementation and initial studies show that high
subsidies were necessary to foster uptake, but that pa-
tient compliance to test results was generally poor.b
Further, little consumer demand exists for malaria diag-
nosis given the wide availability of cheap anti-malarial
drugs; presumptive treatment is still the norm [23,24]. Al-
though RDTs may improve the quality of malaria case
management, nothing is known about the acceptability of
RDTs and the adherence to treatment among customers
at private sector drug shops in Nigeria. To stem presump-
tive treatment and improve appropriate care for acute
malaria episodes, sick individuals must become comfort-
able with a new care protocol: they must accept testing be-
fore treatment, believe in the test results, and take the
correct treatment.
We hypothesize that risk preferences among sick indi-
viduals influence care-seeking behavior and are associ-
ated with the acceptability and valuation of RDTs.
Because the RDT is a health technology that confers in-
formation about health status, it is a priori unclear how
individuals of different risk preferences may perceive
RDTs. This is because there are two types of uncertain-
ties involved in the use of an RDT—one questioning the
validity of the RDT device itself and one regarding a per-
son’s malaria status—and individuals may prefer to re-
duce one uncertainty over the other. On the one hand,
risk averse individuals may be hesitant to adopt and lis-
ten to a new technology if they feel uncertain about the
integrity of the device, preferring to presumptively self-
treat based on prior experiences. On the other hand, the
introduction of diagnostic information reduces the un-
certainty of having the suspected illness and risk averse
individuals may express more affinity for the test due to
the elimination of disease status uncertainty.
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ity of this relationship and the influence of other sociode-
mographic confounders through which risk preferences
may influence health behaviors and the uptake of diagnos-
tic information. From a sample of adult customers with
anti-malarial medication purchases from private drug
shops in Nigeria who agreed to be surveyed and take a free
RDT, we analyzed their self-reported care-seeking and
treatment behaviors and RDT acceptability in relation to
their choice in a simple lottery game designed to assess
risk preferences.
Methods
Study area and sample selection
This study took place in urban and peri-urban areas of
Oyo State in southwest Nigeria, in and around the cities
of Ibadan and Ogbomosho. The population is predomin-
antly of Yoruba descent and all study survey data collec-
tors and nurses were fluent in both English and the
Yoruba language. Oyo state is holoendemic for malaria;
over 50% of the population have one attack per year and
children under five experience two to four episodes per
year [20].
Drug shops were chosen as the best site for participant
recruitment because most individuals in Nigeria obtain
malaria treatment from these vendors [20]. From all enu-
merated drug shops within four selected local government
areas, a total of 50 shops—pharmacies or proprietary and
patent medicine vendors (PPMVs)—were stratified by type
and randomly selected, 43 of which agreed to participate
in the study and to serve as enrollment sites (21 pharma-
cies and 23 PPMVs). In October 2012, two members of
the survey team, one trained nurse and one researcher,
were stationed at enrolled shops on randomly selected
days of the week (excluding Sunday) and approached cus-
tomers as they exited the drug store to assess eligibility.
Participants were eligible for the study if they were an
adult (aged 18 or over), not pregnant, had just purchased
treatment for malaria for him- or herself, and would be
willing to have an RDT conducted for free. Individuals
purchasing malaria treatment for others were excluded.
During screening, participants were made aware that they
would be compensated for their time with a small mobile
phone credit of 100 Naira (~US$0.63) paid at the end of
the interview and would be invited to earn more based on
the outcome of a game (risk preference game detailed
below). All compensation amounts were vetted and pre-
tested with local experts to determine feasible amounts
that would minimize undue influence on an individual’s
willingness to participate.
Data collection
For eligible participants who signed written consent to
participate, two surveys were conducted—one at thetime of enrollment and testing (i.e. baseline) and one
four days after the initial encounter via phone (i.e.
follow-up). At baseline, the eligible participant was given
a RDT (free of charge) by a trained nurse at the begin-
ning of the survey. While the RDT result was pending
(about 15 minutes), a short survey was administered, in-
cluding an inventory of drugs purchased. Contact infor-
mation was recorded to enable later phone follow-up. At
the end of the survey, the participant was provided with
the result of his or her test.
Nurses were instructed to provide participants with
standard advice according to their RDT results. If the
participant tested positive for malaria, s/he was told that
the positive result indicated the presence of malaria. Per
ethical considerations and to ensure that the participants
testing positive had a quality-assured anti-malaria drug,
a free course of ACTs was provided and participants
were instructed to take the quality-assured ACT instead
of the anti-malarial drugs s/he purchased on her/his
own. If the test was negative, the participant was told
that the negative result indicated the absence of malaria
and that the anti-malarial drugs they purchased were
not needed. Regardless of the test result, all participants
were referred to local clinics and hospitals where they
could seek care if their condition was not malaria, or if
their illness became worse. In a parallel study of a random-
ized intervention to influence RDT adherence, selected
participants were sent a SMS text message reminder of the
RDT results one day after the baseline survey [25]. This
component of the study was unrelated to the risk prefer-
ence assessment, and analyses show no relationship of the
SMS intervention to risk game choices analyzed here [25].
Four days after the baseline survey, a study nurse called
each participant and conducted a phone interview to ob-
tain self-reported information on the state of their health
and the drugs they had used. A total of 465 adults were
enrolled in the baseline survey, but eight were excluded
due to survey numbering errors, and 424 participated in
the follow-up phone survey. Less than 4% of participants
were RDT-positive among all enrolled. Because of the ex-
ploratory nature of the risk preference analysis, no power
calculations were conducted to a priori determine a target
sample size.
Measuring health behaviors and RDT acceptability
During the baseline survey, we asked participants about
their usual and current care-seeking behavior for mal-
aria: having ever had a blood test, usual diagnostic
method, severity of illness the last time s/he had malaria,
type of provider seen for the last suspected episode, the
number of days waited before seeking care, source of
their diagnosis, and their drug purchases.
To assess acceptability and valuation of RDTs, we used
two measures. First, we asked respondents two rounds
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survey after participants received their RDT result while
individuals were feeling sick and again during the phone
follow-up survey after individuals should have recovered
from their illness. We modified contingent valuation
methods in other RDT valuation studies [24,26] and used
a bidding approach: starting with a market price of 200
Naira (~US$1.20) and depending on the respondent’s
answer, the amount was marked down by 50 Naira incre-
ments with a final bid of 20 Naira before a floor of zero
was reached, or marked up by 50 Naira with a final bid of
400 Naira before a ceiling of 500 Naira was reached. Re-
spondents could bid as many times as they desired and
their last bid was taken to represent their willingness to
pay. Because RDTs are not widely available and few re-
spondents had previously experienced an RDT, a compari-
son of the two measures of willingness to pay enables
us to examine changes in valuation rather than levels,
which may be inaccurate and confounded by past experi-
ences or individuals’ priors with diagnostic procedures.
The increase in willingness to pay for an RDT is arguably
a more accurate reflection of the participants’ acceptability
of the RDT and is purposely designed to allow individuals
to have time to learn the value of the RDT over the course
of the illness recovery. Second, treatment adherence to
RDT results, an indirect measure of the value of diagnostic
information, was determined through the follow-up phone
survey in which nurses asked respondents about drugs
taken. We considered a respondent to have followed the
treatment directions if s/he took the anti-malarial when
RDT-positive or if s/he did not take the anti-malarial when
RDT-negative.
Measuring risk preferences
We assessed risk preferences using a simplified lottery
game choice set, which was part of the baseline survey.
Respondents chose one lottery game to play amongst
three game options: (1) 50% chance of winning 200 Naira
vs. 50% chance of winning 200 Naira; (2) 50% chance of
winning 100 Naira vs. 50% chance of winning 300 Naira;
and (3) 50% chance of winning 0 Naira vs. 50% chance of
winning 400 Naira. Experimental designs for measuring
risk preferences require subjects to have an understanding
of probabilistic events and calculations and are likely to be
more challenging for less-educated populations [27]. Be-
cause we were unable to assess numeracy skills, choices in
the lottery games were simplified so that the probabilities
of win/loss and expected payouts were constant. While
imperfect for mimicking risk aversion, we made these sim-
plifications to isolate only risk preferences associated with
the variance in payouts and minimize confounding due to
miscalculated probabilities. The winning amount was paid
in the form of mobile phone credits. Prior to enrollment,
respondents were informed that they would have a chanceto gain additional phone credits, but the amounts were
not specified.
Data analysis
Survey data were independently entered into database
interface forms using a standardized data dictionary and
compared for errors and corrections. A 10% random
check was performed to ensure 99.5% data entry accur-
acy. A second round of quality checks were conducted
for all data fields in the codebook to examine outliers
and miscodes on an individual case-by-case basis. Where
discrepancies were found, data inputs were crosschecked
with the original paper survey for final reconciliation.
All indeterminate cases were coded to missing.
We first explored the profiles of individuals according
to their risk game choice to assess the internal validity of
the game measure. We compared basic sociodemo-
graphic characteristics—age, sex, martial status, educa-
tion, employment, and wealth—across game choices by
graphing the probability density function of participants’
ages. Differences in the full age profiles of individuals
choosing different risk games was tested using the
Kruskal-Wallis equality-of-populations rank test. Wealth
quintiles were constructed using standard principal com-
ponents analysis of household asset indicators [28].
We then applied bivariable and multivariable regression
analyses to examine relationships between risk game
choices, different malaria care-seeking behaviors, and po-
tential mediating pathways. We selected predictors based
on a priori hypotheses of determinants of health behavior,
including unobservable risk preferences vis-à-vis the risk
game choice and observable sociodemographic character-
istics. We then chose two behavioral outcomes that were
statistically significant from bivariable analyses—having
ever had a blood test for malaria, and waiting three or
more days before seeking care for the current illness—
were then chosen for further multivariable analysis. We
then introduced observable sociodemographic characteris-
tics—demographic profile, education, and wealth—indi-
vidually and separately to examine the contributions of
these factors for mediating the relationship between risk
game choices and behavioral outcomes. Interaction effects
between risk game choices and education and wealth indi-
cators were explored, but not reported because of the lim-
ited sample size. We used logistic regressions for all
outcome measures, standard errors were clustered by drug
retail site, and Wald statistics are reported for each regres-
sion equation. P-values for Wald tests of joint significance
are also reported for categorical variables. All data analysis
was conducted using Stata MP version 12.
Ethical considerations
The Nigerian Health Research Ethical Review Commit-
tee and the University of California, San Francisco’s
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tocols. Surveyors obtained informed consent from study
participants and shop proprietors where the customers
were recruited. Funding sponsors for the study did have
any role in the study design, execution, or publication.
Results
Of 448 individuals who agreed to participate in the risk
game, 63.2% (n = 283) chose the game with a certain
payout of 200 Naira, 27.9% (n = 125) chose the game with
a chance of either 100 or 300 Naira payout, and 8.9%
(n = 40) chose the game with the largest payout variance, 0
or 400 Naira (see Table 1). Individuals choosing different
game choices were marginally significantly different by sex
and education, and significantly different by age. Nearly
68% of individuals choosing the 0/400 Naira game were
male versus only 45.6% of those choosing the 100/300
Naira game and 50.2% of those choosing the 200/200 Naira
game. Compared to 200/200 Naira group, individuals
choosing the 0/400 Naira game were slightly older and
those choosing the 100/300 Naira game were generally
younger; the full age profile of the 0/400 Naira group lies
everywhere to the right of the 100/300 Naira group (see
Figure 1). The 200/200 Naira group was somewhat betterTable 1 Sample characteristics
Sample overall
Sex % Male 50.4
Age1 Median age 36.4
CI [20.0-63.0]
Marital status % Married 67.4
Education % Less than primary 8.5
% Primary 14.3
% Secondary 39.3
% More than secondary 37.9
Employment status2 % Employed full time 28.2
% Employed part time 2.9
% Self-employed 53.7
% Unemployed 15.2







95% Confidence intervals (CI) in brackets.
*** p < 0.01, ** p < 0.05, * p < 0.10.
1Age distribution differences tested by the Kruskal-Wallis equality-of-populations ra
2N = 447 due to 1 missing observation.educated than others with only 19.4% having primary
schooling or less compared with 29.6% and 25.0% of the
100/300 Naira and 0/400 Naira groups, respectively. There
were statistically significant differences in employment sta-
tus across risk game groups: 50.7% of the 200/200 Naira
group was self-employed compared to 59.2% and 57.5% of
the 100/300 Naira and 0/400 Naira groups, respectively.
Differences in usual malaria care-seeking practices and
specifically for the current illness are summarized in
Table 2. Testing for malaria is generally low: 61.4% have
ever had a blood test and 22.8% report that testing or
examinations are part of their usual malaria care-seeking
behavior. More individuals in the 0/400 Naira group re-
ported having ever had a blood test for malaria (74.4%
compared to 52.1% of the 100/300 Naira group and
63.7% of the 200/200 Naira group), and these differences
were statistically different. While other usual malaria care-
seeking behaviors were not significantly different, some
trends across risk game groups were observed: a higher
percentage of individuals in the 0/400 Naira group re-
ported being completely disabled (defined as “not being
able to perform any normal activities”) and obtaining care
at a PPMV during their last malaria episode than among
other risk game groups.Risk game chosen
200/200 100/300 0/400 p for diff
50.2 45.6 67.5 *
38.0 33.0 40.0 **
[21.0-63.0] [19.0-64.0] [22.0-64.0]
67.8 64.0 75.0















nk test (p = 0.015).
Figure 1 Kernel density distribution of participants’ ages by risk game chosen. Legend: Compared to 200/200 Naira group (blue),
individuals choosing the 0/400 Naira game (green) were slightly older and those choosing the 100/300 Naira game (red) were generally younger;
the full age profile of the 0/400 Naira group lies everywhere to the right of the 100/300 Naira group. Age distributions across risk games were
significantly different (p = 0.015), tested using the Kruskal-Wallis equality-of-populations rank test.
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waited three or more days before seeking care; the per-
centage was significantly lower for those in the 0/400
Naira group (18.9%) and higher for those in the 100/300
Naira group (40.5%). Self-diagnosis is generally high and
not different across risk game groups. No differences in
drug purchases, amount paid, and RDT-positivity were
observed. While differences in RDT acceptability mea-
sures were also not detected, fewer individuals in the 0/
400 Naira group (64.9%) followed RDT result-specific
treatment directions compared to the 100/300 Naira
group (74.5%) and the 200/200 Naira group (73.2%). In
terms of willingness to pay for an RDT, fewer individuals
in the 0/400 Naira group (5.3%) reported an increase in
their willingness to pay for an RDT compared to other
risk game groups (12.8% among the 100/300 group and
12.9% among the 200/200 group). These changes were
largely driven by a decline in mean willingness to pay
between baseline and follow-up within the 0/400 Naira
group. In contrast, mean willingness to pay increased
over time for the other risk game groups.
Multivariable regression analyses that investigate pos-
sible associations between risk preferences and health
behaviors were statistically significant in bivariable ana-
lyses (i.e. having ever had a blood test, waiting three or
more days before seeking care) are displayed in Tables 3
and 4. For having ever had a blood test for malaria
(Table 3), the point estimates on risk game choices do
not substantively change across specifications; this sug-
gests that there is little confounding from the additional
controls. When additional sociodemographics variablesare added, risk game choices are jointly significant for
most specifications with marginal joint significance
showing when education is controlled for (column 3). In
column 2, the significantly lower likelihood associated
with choosing the 100/300 Naira game becomes margin-
ally significant when demographic variables are added.
Choosing the game with the highest variance (0/400
Naira) is associated with a higher, but not statistically
significant likelihood of ever having a blood test. Mar-
ried individuals and those from Ibadan are nearly twice
as likely as their unmarried or Ogbomosho counterparts
to ever have had a blood test. With education added
(column 3), neither risk game choice is statistically sig-
nificant. Education alone is highly predictive of increased
likelihood of testing by more than three-fold. When
wealth measures are separately included (column 4), the
estimated effects of risk game choices are similar, are in-
dividually marginally significant, and are jointly signifi-
cant. Estimates on wealth measures indicate a steep
gradient with the wealthiest being five times more likely
to have ever been tested. Education and wealth remain
significant predictors when all controls are added to-
gether (column 5).
When examining days waited before seeking care
(Table 4), the joint significance of risk game choices fluc-
tuates around the 5% significance level across difference
specifications and the addition of education and wealth
measures also does not substantively change the individ-
ual point estimates. With just demographic controls
(column 2), neither risk category is statistically significant,
but being female and residing in Ibadan is associated with
Table 2 Differences in malaria care-seeking and treatment behavior by risk game
Risk game chosen
N Sample overall 200/200 100/300 0/400 p for diff
Usual malaria care-seeking behavior
% Ever had blood test for malaria 438 61.4 63.7 52.1 74.4 ***
% Usually gets diagnosed with a test 448 22.8 23.3 22.4 20.0
% Usually diagnosed via provider consult 448 31.5 29.0 36.8 32.5
% Was completely disabled due to illness last time had malaria 436 16.7 15.9 16.4 23.7
% Saw PPMV last time suspected malaria 422 41.5 39.6 42.5 51.4
Care-seeking behavior for current illness
Waited 3 or more days before seeking care 414 34.8 34.5 40.5 18.9 **
% Diagnosed by myself/family/friend 447 91.5 90.8 92.7 92.5
% Bought an ACT 410 44.4 43.7 44.5 48.6
% Bought an additional symptom drug 417 61.9 61.9 61.3 63.2
% RDT-positive 448 4.0 4.6 3.2 2.5
Mean amount paid for drugs 434 381.7 396.7 353.1 366.3
CI [341.6-421.9] [342.7-450.8] [291.9-414.4] [25.96-516.6]
Treatment for current illness1
Followed treatment directions2 407 73.2 73.8 74.5 64.9
Took non-malaria drugs3 255 77.6 77.8 76.8 79.2
Increased willingness to pay for an RDT from baseline 403 12.2 12.9 12.8 5.3
Baseline mean (Naira) 403 402.7 396.9 410.6 419.7
CI [390.1-415.4] [380.8-413.0] [386.5-434.6] [378.5-461.0]
Follow-up mean (Naira) 403 405.6 401.6 416.1 402.6
CI [393.3-417.9] [385.8-417.3] [393.2-439.9] [361.6-445.7]
95% Confidence interval in brackets.
*** p < 0.01, ** p < 0.05, * p < 0.10.
1 Restricted to those who were followed up by phone.
2 Defined as taking anti-malarial drugs if RDT-positive and not taking anti-malarial drugs if RDT-negative.
3 Restricted to those who purchased non-malaria drugs.
160 Naira is equivalent to about US$1.00.
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tion is also associated with a higher likelihood of waiting
longer (column 3), but wealth does not appear to have an
independent effect (columns 4–5). In the final specifica-
tion with the full set of controls, the point estimates on
risk game and education variables increase as do statistical
significance levels. In sensitivity analyses (not shown),
polynomial age and employment status variables added to
regression specifications were neither statistically or sub-
stantively significant.
Discussion
From a pilot study of malaria case management at drug
vendors in Oyo State, Nigeria, we find suggestive evidence
that a fundamental trait, risk preferences, may be influen-
cing individuals’ behaviors in treating suspected malaria.
With the offering of three simplified games with constant
expected values but different payout variances, nearly two-
thirds of respondents chose the game without any risk andless than 10% chose the game with the highest payout
variance. A comparison of basic demographics between
risk profiles suggests that our measure of risk preference
may be valid and in line with conventional findings (e.g.
[29]): individuals choosing games with some variance in
payouts were more likely to be male, self-employed, and
less educated compared to those choosing games with a
certain payout. Contrary to usual findings from devel-
oped countries (e.g. [30]), respondents choosing the
“riskiest” game with the highest payout variance were
generally older than their less risky counterparts. This
divergence may be related to cultural perceptions of se-
niority and rank, but further qualitative analysis is
needed to better characterize this finding and a larger
sample size is needed to better assess the external valid-
ity of the risk game measure.
According to RDT results, respondents did not differ by
malaria burden across risk groups, but they approached
care-seeking in somewhat different ways. While a number
Table 3 Logistic regressions predicting the likelihood of ever having a blood test for malaria (odds ratios)
Ever had blood test for malaria
(1) (2) (3) (4) (5)
Risk game (reference: Game 200/200)
Game 100/300 0.620** 0.651* 0.736 0.668* 0.728
[0.393 - 0.977] [0.406 - 1.045] [0.459 - 1.180] [0.415 - 1.076] [0.449 - 1.180]
Game 0/400 1.655 1.779 1.978 2.073* 2.112*
[0.722 - 3.794] [0.726 - 4.362] [0.790 - 4.957] [0.937 - 4.587] [0.922 - 4.834]
Joint test p-value 0.039 0.070 0.020 0.038
Male (reference: female) 0.890 0.808 0.797 0.772
[0.606 - 1.308] [0.531 - 1.231] [0.527 - 1.204] [0.500 - 1.194]
Age (reference: 18–29)
30-39 0.942 0.913 1.003 0.960
[0.522 - 1.699] [0.519 - 1.608] [0.549 - 1.832] [0.539 - 1.712]
40-49 1.338 1.373 1.388 1.382
[0.628 - 2.851] [0.638 - 2.956] [0.649 - 2.969] [0.636 - 3.004]
50+ 1.590 2.063** 1.776** 2.031**
[0.886 - 2.853] [1.134 - 3.755] [1.004 - 3.141] [1.100 - 3.751]
Joint test p-value 0.081 0.008 0.033 0.019
Married (reference: not married) 1.777** 1.840** 1.665* 1.735*
[1.079 - 2.927] [1.070 - 3.164] [0.981 - 2.826] [0.992 - 3.034]
Recruited at PPMV (reference: pharmacy) 0.707 0.847 0.835 0.908
[0.454 - 1.101] [0.510 - 1.407] [0.512 - 1.363] [0.531 - 1.552]
Ibadan (reference: Ogbomosho) 2.181*** 2.192*** 1.561* 1.757**
[1.406 - 3.382] [1.345 - 3.574] [0.945 - 2.580] [1.020 - 3.027]
Education (reference: less than primary)
Primary 1.105 1.068
[0.478 - 2.554] [0.484 - 2.360]
Secondary 2.017 1.539
[0.774 - 5.254] [0.636 - 3.720]
Higher 3.656*** 2.413**
[1.473 - 9.077] [1.042 - 5.591]
Joint test p-value 0.012 0.040
Wealth (reference: poorest quintile)
Second 1.562 1.200
[0.876 - 2.783] [0.690 - 2.085]
Third 1.992** 1.571
[1.026 - 3.866] [0.868 - 2.843]
Fourth 2.742** 1.836*
[1.244 - 6.043] [0.905 - 3.728]
Richest 5.156*** 3.304***
[2.633 - 10.098] [1.781 - 6.129]
Joint test p-value 0.000 0.003
N 438 438 438 438 438
Wald chi2 (df ) 9.4 (2) 106.1 (9) 86.2 (12) 123.5 (13) 140.4 (16)
p <0.01 <0.001 <0.001 <0.001 <0.001
Standard errors are clustered at the shop level.
95% Confidence intervals in brackets.
*** p < 0.01, ** p < 0.05, * p < 0.10.
p-values for Wald statistics reported for joint tests.
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Table 4 Logistic regressions predicting the likelihood of waiting three or more days before seeking care (odds ratios)
Waited 3 days or more before seeking care
(1) (2) (3) (4) (5)
Risk game (reference: Game 200/200)
Game 100/300 1.294 1.434 1.519 1.416 1.538*
[0.828 - 2.023] [0.879 - 2.339] [0.919 - 2.511] [0.874 - 2.292] [0.929 - 2.545]
Game 0/400 0.443* 0.512 0.521* 0.487* 0.458**
[0.194 - 1.011] [0.230 - 1.141] [0.246 - 1.103] [0.221 - 1.075] [0.227 - 0.923]
Joint test p-value 0.064 0.045 0.050 0.018
Male (reference: female) 0.595* 0.565** 0.608* 0.577**
[0.349 - 1.015] [0.334 - 0.958] [0.364 - 1.017] [0.347 - 0.961]
Age (reference: 18–29)
30-39 0.945 0.929 0.946 0.905
[0.526 - 1.698] [0.517 - 1.669] [0.526 - 1.702] [0.514 - 1.594]
40-49 1.110 1.140 1.119 1.148
[0.597 - 2.062] [0.616 - 2.107] [0.558 - 2.245] [0.591 - 2.231]
50+ 1.558 1.714 1.597 1.906*
[0.869 - 2.791] [0.880 - 3.336] [0.803 - 3.176] [0.919 - 3.951]
Joint test p-value 0.196 0.188 0.268 0.092
Married (reference: not married) 1.311 1.209 1.328 1.269
[0.886 - 1.941] [0.823 - 1.775] [0.890 - 1.980] [0.890 - 1.810]
Recruited at PPMV (reference: pharmacy) 0.907 0.994 0.883 0.952
[0.605 - 1.360] [0.646 - 1.529] [0.570 - 1.368] [0.594 - 1.527]
Ibadan (reference: Ogbomosho) 3.640*** 3.657*** 3.907*** 4.481***
[1.665 - 7.957] [1.692 - 7.900] [1.676 - 9.112] [1.889 - 10.627]
Education (reference: less than primary)
Primary 2.586** 2.847***
[1.216 - 5.499] [1.303 - 6.220]
Secondary 1.830 2.498*
[0.730 - 4.585] [0.970 - 6.434]
Higher 3.190*** 5.113***
[1.470 - 6.923] [2.021 - 12.936]
Joint test p-value 0.008 0.003
Wealth (reference: poorest quintile)
Second 0.861 0.658
[0.300 - 2.470] [0.224 - 1.932]
Third 1.034 0.804
[0.451 - 2.369] [0.346 - 1.869]
Fourth 0.606 0.362*
[0.236 - 1.556] [0.123 - 1.067]
Richest 0.863 0.477
[0.424 - 1.754] [0.189 - 1.202]
Joint test p-value 0.410 0.172
N 414 414 414 414 414
Wald chi2 (df ) 6.5 (2) 48.9 (9) 64.3 (12) 51.8 (13) 78.3 (16)
p <0.05 <0.001 <0.001 <0.001 <0.001
Standard errors are clustered at the shop level.
95% Confidence intervals in brackets.
*** p < 0.01, ** p < 0.05, * p < 0.10.
p-values for Wald statistics reported for joint tests.
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statistically significantly different across risk groups, the
direction of the differences tend to align and point to two
divergent ways for approaching healthcare. Analysis of risk
game profiles in relation to health behaviors suggest that
individuals who prefer less risk vis-à-vis their game choice
tended to be more “conservative” while those who pre-
ferred more risk tended to be less cautious. From bivari-
able analyses, respondents choosing the least risky, certain
payout game were more likely to ever have had a blood
test, and less likely to visit PPMVs, report fewer debilitat-
ing effects of malaria, and seek care later. In particular, the
“riskiest” group choosing the highest variance game ap-
pears to be a highly select group of individuals who may
have more health experiences, interactions with the health
care sector, or have more health problems in general, such
as due to natural aging, but even after controlling for age,
these differences in behavior remained.
However, not all behaviors accord perfectly with this
simplification across risk groups; the behavior of individ-
uals in the moderate variance (i.e. 100/300 Naira) group
sometimes aligned more with the no variance group (i.e.
200/200 Naira) and sometimes aligned more closely with
those in the highest variance group (i.e. 0/400 Naira).
This was also evident in multivariate analyses in which
the direction for the effect for the high-risk (0/400)
group differed from the moderate risk group (100/300)
when compared to the no risk group (200/200) group.
The differences were only sometimes statistically signifi-
cant, suggesting that the moderate risk individuals may
sometimes display similar intolerance (i.e. when not sig-
nificantly different) or even more intolerance (i.e. when
significantly different) for risk as the no risk group. Bet-
ter differentiation and characterization of this moderate
group is needed and with potentially different game pay-
out structures.
Poorer or less educated individuals are generally
thought to have lower health status, face greater barriers
to accessing health services, and be subject to tighter in-
come constraints. In the Nigerian context, PPMVs pro-
vide lower quality drugs and care than pharmacists and
disproportionately serve the poor (and potentially sicker)
populations [20,31]. Education was a strong predictor
for both behaviors investigated and a strong wealth gra-
dient was observed for the likelihood of ever having had
a blood test for malaria. Even though these socioeco-
nomic status indicators were predictive of certain behav-
iors, point estimates of the effects of risk game choices
remained substantively unchanged, even after controlling
for various sets of confounders, suggesting possible inde-
pendent effects of unobservable risk preferences.
One unique contribution of this study is that risk pref-
erences are evaluated in relation to the introduction of a
health device, the uptake of new information, and theimplications of diagnostic certainty on actual treatment
behaviors. Although results are not statistically signifi-
cant for any treatment outcomes (owing to the small
sample size), the directionality of the observed relation-
ships suggest that individuals of varying risk types may
approach health information differently, at least among
those seeking care for suspected malaria in our sample.
Compared to individuals in the “riskiest” group with less
cautious care-seeking behavior, a higher proportion of
those in the zero- and low-variance (i.e. 200/200 and
100/300 Naira) risk groups reported following the cor-
rect treatment procedure and an increase in willingness
to pay for an RDT. This may be related to a greater un-
derstanding or learning of the value of diagnostic testing
over the course of illness recovery. In fact, individuals in
the riskiest group reduced their willingness to pay for
the RDT over time, suggesting that they value the diag-
nostic information less and do not view the RDTs to be
as a useful a device as others. Health promotion for
RDTs should bear these harder-to-convince individuals
in mind when designing and framing messages. While
the overall high rate of treatment adherence to RDT re-
sults indicates generally high acceptability of RDTs, it is
unclear if introducing RDTs would decrease presumptive
treatment over the long-term. Studies elsewhere show
that reduced misdiagnosis and positive experiences with
health products can foster stronger learning effects and
increase adoption.c
These results should be interpreted in light of several
caveats. Because of the targeted recruitment at drug
shops, the study population is not a representative sam-
ple of all adults with suspected malaria, limiting the
broader generalizability of these findings. Within our
sample, levels of reported willingness to pay should not
be taken out of context and used to infer market pricing,
as individuals’ responses were not elicited for that pur-
pose. Further, in our analysis, there may be other unob-
served traits that explain differences in care-seeking
behaviors. For example, rather than being a riskier per-
son, individuals might be time inconsistent and seek im-
mediate gratification for the condition, especially when
sick. In a companion paper, we find a significant effect
of an SMS reminder message of RDT results to “nudge”
participants to overcome time inconsistency and follow
the correct treatment, but there was no additional inter-
action with risk game choices [25]. Future work should
seek to additionally assess the contributions of time
preferences, the initial state of health (sick versus well),
and include a larger game choice set with graduated pay-
outs to better characterize risk aversion. In particular,
we find only 8.9% of our sample took up the riskiest
game. These individuals may have another unobserved
common trait, such as numeracy, which is related to
both their risk preference and health behaviors. Risk
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of RDTs to test whether these same relations emerge.
Estimates from this pilot study will serve as the basis for
sample size calculations of the expanded study that will
enable a more thorough multivariable analysis of risk
preferences. Finally, it is important to note that all health
outcome measures are self-reported and that there may
be important mediating factors, such as where and from
whom participants received advice on appropriate mal-
aria diagnosis and treatment, which may influence care-
seeking behaviors. Future studies should seek to assess
the contributions of these factors independent from an
individual’s fundamental risk preferences.
Conclusion
While more research is needed to explain care-seeking
behaviors of individuals with different preferences and
traits, the main findings of this exploratory study sug-
gests that risk preferences may independently influence
the way individuals process health information from a
newly introduced health technology. Communications
designed to change behavior often ignore differences in
the uptake and processing of health advice. Messages de-
livered through either provider-patient interactions or
targeted social mobilization can include multiple mes-
sage frames in order to reach individuals with varying
preferences. Different modalities need to be tested to as-
sess what decision frame resonates most with different
groups. In particular, crafting messages that appeal to
the unique concerns of different risk types would in-
crease the reach of interventions, and specifically in this
case, work to enhance the adoption of RDTs and in-
crease the demand for testing before treatment.
Endnotes
aTarozzi A, Mahajan A, Blackburn B, Kopf D, Krishnan
L, and Yoong J: Micro-loans, bednets and malaria:
Evidence from a randomized controlled trial in Orissa
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1941. Cohen, J., Dupas, P., & Schaner, S. (2013). Price
subsidies, diagnostic tests, and targeting of malaria treat-
ment: Evidence from a randomized controlled trial.
NBER Working Paper No. 17943. Available online at
http://www.nber.org/papers/w17943. Accessed on March
20, 2013.
bSee Cohen, J., Dupas, P., & Schaner, S. (2013). Price
subsidies, diagnostic tests, and targeting of malaria treat-
ment: Evidence from a randomized controlled trial.
NBER Working Paper No. 17943. Available online at
http://www.nber.org/papers/w17943. Accessed on March
20, 2013.
cSee Adhvaryu, A. R. (2012). Learning, misallocation,
and technology adoption: Evidence from new malaria ther-
apy in Tanzania (available online at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1357771) and Dupas, P.
(2012). Short-run subsidies and long-run adoption of new
health products: Evidence from a field experiment. CEGA
Working Paper Series No. 011 (available online at http://
escholarship.org/uc/cega_wps)
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